Nexalin Technology, Inc. (NXL) stock
NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.38−0.01 (-0.72%)
Close on Nov 20, 2026Market cap $30.41MP/E –Yield –
Nexalin Technology revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Nexalin Technology's revenue for the twelve months ending Jun 30, 2026 was $217.16K, up 24.2% year over year. For fiscal 2025 it was $301.65K, up 78.8% from the year before. The highest annual figure on record is $1.32M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $301.65K | +78.8% |
| FY2024 | Dec 31, 2024 | $168.72K | +52.3% |
| FY2023 | Dec 31, 2023 | $110.75K | -91.6% |
| FY2022 | Dec 31, 2022 | $1.32M | +817.2% |
| FY2021 | Dec 31, 2021 | $144.07K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $12.16K | -82.8% |
| Q1 FY2026 | Mar 31, 2026 | $14.95K | -63.5% |
| Q4 FY2025 | Dec 31, 2025 | $171.90K | +532.5% |
| Q3 FY2025 | Sep 30, 2025 | $18.15K | -49.6% |
| Q2 FY2025 | Jun 30, 2025 | $70.59K | +163.0% |
| Q1 FY2025 | Mar 31, 2025 | $41.02K | -47.9% |
| Q4 FY2024 | Dec 31, 2024 | $27.18K | -23.5% |
| Q3 FY2024 | Sep 30, 2024 | $36.03K | +17.9% |
| Q2 FY2024 | Jun 30, 2024 | $26.84K | -30.1% |
| Q1 FY2024 | Mar 31, 2024 | $78.67K | -85.6% |
| Q2 FY2023 | Jun 30, 2023 | $35.54K | -91.4% |
| Q1 FY2023 | Mar 31, 2023 | $30.56K | -90.5% |
| Q4 FY2022 | Dec 31, 2022 | $38.42K | +60.1% |
| Q3 FY2022 | Sep 30, 2022 | $545.32K | +874.3% |
| Q2 FY2022 | Jun 30, 2022 | $414.29K | – |
| Q1 FY2022 | Mar 31, 2022 | $323.32K | – |
| Q4 FY2021 | Dec 31, 2021 | $24.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $55.97K | – |
See a number that looks wrong?